Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration

Eur J Heart Fail. 2007 Apr;9(4):403-8. doi: 10.1016/j.ejheart.2006.10.018. Epub 2006 Dec 12.

Abstract

Background: Myocardial viability assessment in severely dysfunctional segments by dobutamine stress echocardiography (DSE) is less sensitive than nuclear scanning.

Aim: To assess the additional value of using the recovery phase of DSE after acute beta-blocker administration for identifying viable myocardium.

Methods: The study included 49 consecutive patients with ejection fraction (LVEF)<or=35%. All patients underwent DSE evaluation at low-high dose and during recovery phase, and dual-isotope single photon emission tomography (DISA-SPECT) evaluation for viability of severely dysfunctional segments. Patients with >or=4 viable segments were considered viable. Coronary revascularization followed within 3 months in all patients. Radionuclide evaluation of LVEF was performed before and 12 months after revascularization.

Results: Viability with DISA-SPECT was detected in 463 (59%) segments, while 154 (19.7%) segments presented as scar. The number of viable segments increased from 415 (53%) at DSE to 463 (59%) at DSE and recovery, and the number of viable patients increased from 43 to 49 respectively. LVEF improved by >or=5% in 27 patients. Multivariate regression analysis showed that, DSE with recovery phase was the only independent predictor of >or=5% LVEF improvement after revascularization (OR 14.6, CI 1.4-133.7).

Conclusion: In this study, we demonstrate that the recovery phase of DSE has an increased sensitivity for viability estimation compared to low-high dose DSE.

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / pharmacology*
  • Coronary Artery Disease / diagnostic imaging*
  • Coronary Artery Disease / physiopathology
  • Echocardiography, Stress
  • Female
  • Heart / drug effects*
  • Heart Rate
  • Humans
  • Male
  • Middle Aged
  • Myocardium*
  • Radionuclide Ventriculography
  • Recovery of Function
  • Stroke Volume
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Adrenergic beta-Antagonists